Targeting RAS Signaling Pathways in Juvenile Myelomonocytic Leukemia

By  

Current Drug Targets, Vol. 8, Iss. 6, 2007-06 ,pp. : 715-725

Bentham Science Publishers

Access to resources Recommend Favorite

Juvenile Myelomonocytic Leukemia: Epidemiology, Etiopathogenesis, Diagnosis, and Management Considerations

By Yoshimi Ayami  

Pediatric Drugs, Vol. 12, Iss. 1, 2010-02 ,pp. : 11-21

Adis International

Access to resources Recommend Favorite

Arsenic trioxide for management of acute promyelocytic leukemia: current evidence on its role in front-line therapy and recurrent disease

By Breccia Massimo   Lo-Coco Francesco  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 7, 2012-05 ,pp. : 1031-1043

Informa Healthcare

Access to resources Recommend Favorite

Across the Universe of K-Ras Mutations in Non-Small-Cell-Lung Cancer

By  

Current Pharmaceutical Design, Vol. 20, Iss. 24, 2014-05 ,pp. : 3933-3943

Bentham Science Publishers

Access to resources Recommend Favorite

Impact of missense mutations on biosynthesis of myeloperoxidase

By Nauseef W.M.   McCormick S.   Goedken M.  

Redox Report, Vol. 5, Iss. 4, 2000-08 ,pp. : 197-206

Maney Publishing

Access to resources Recommend Favorite